Cell-mediated immune status of children with recurrent infection

Objective: To evaluate the cell-mediated immune status of children with recurrent respiratory tract infections. Design: We evaluated the cell-mediated immune status of 76 patients referred because of recurrent infection. Patients were divided into those with serologic abnormalities and those without...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 1995-04, Vol.126 (4), p.530-536
Hauptverfasser: Herrod, Henry G., Blaiss, Michael S., Valenski, William R., Gross, Sharon
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Objective: To evaluate the cell-mediated immune status of children with recurrent respiratory tract infections. Design: We evaluated the cell-mediated immune status of 76 patients referred because of recurrent infection. Patients were divided into those with serologic abnormalities and those without such findings. Twenty-three healthy children served as control subjects. Studies of lymphocyte phenotype included CD4 + CD29 + cells (an immunologically mature phenotype), lymphocyte proliferation studies, cytokine production including interleukin-2 (IL-2), IL-4, IL-6, and interferon γ), and measurement of in vitro IgM and IgG synthesis. Results: Lymphocyte proliferation and T-cell phenotype were similar in both patient groups as well as in control subjects. The proportions of CD4 + CD29 + cells at different ages were similar in all groups. Patients with serologic abnormalities (e.g., partial IgA deficiency, partial IgG subclass deficiency) produced more IL-2 and IL-4 than did other patients. The control population had greater spontaneous IgM and IgG synthesis than the patient groups. Conclusion: Routine studies of T-cell function of patients with recurrent infection provide little information useful in making clinical decisions. ( J PEDIATR 1995;126: 530-6)
ISSN:0022-3476
1097-6833
DOI:10.1016/S0022-3476(95)70345-4